Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Assets Average (2019 - 2025)

Silo Pharma's Assets Average history spans 7 years, with the latest figure at $6.5 million for Q3 2025.

  • For Q3 2025, Assets Average fell 21.49% year-over-year to $6.5 million; the TTM value through Sep 2025 reached $6.5 million, down 21.49%, while the annual FY2024 figure was $7.6 million, 21.82% down from the prior year.
  • Assets Average for Q3 2025 was $6.5 million at Silo Pharma, up from $6.3 million in the prior quarter.
  • Across five years, Assets Average topped out at $12.3 million in Q4 2022 and bottomed at $3.5 million in Q1 2021.
  • The 5-year median for Assets Average is $8.3 million (2024), against an average of $8.5 million.
  • The largest annual shift saw Assets Average skyrocketed 671.77% in 2021 before it crashed 35.2% in 2024.
  • A 5-year view of Assets Average shows it stood at $10.9 million in 2021, then rose by 12.85% to $12.3 million in 2022, then plummeted by 32.23% to $8.4 million in 2023, then decreased by 4.51% to $8.0 million in 2024, then fell by 18.41% to $6.5 million in 2025.
  • Per Business Quant, the three most recent readings for SILO's Assets Average are $6.5 million (Q3 2025), $6.3 million (Q2 2025), and $6.7 million (Q1 2025).